Benzinga's Top Pre-Market Losers

Ariad Pharmaceuticals

dipped 56.83% to $7.40 in the pre-market session after the company reported that it is pausing patient enrollment in studies of Iclusig. CytRx

dipped 18.25% to $2.24 after the company priced its underwritten public offering of 10.0 million shares of common stock at a price of $2.25 per share. Lexicon Pharmaceuticals

shares fell 7.75% to $2.50 in the pre-market trading after the company reported top-line results from a pilot study exploring the use of telotristat etiprate in ulcerative colitis. Yum! Brands

shares dropped 6.38% to $66.75 in pre-market trading after the company reported a 68% drop in its third-quarter profit and lowered its forecast.